Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?

por Kauffmann, Rondi M., Hamner, J. Blair, Ituarte, Philip H. G., Yim, John H.
Publicado 2018

Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer

por Han, Ernest S., Wen, Wei, Dellinger, Thanh H., Wu, Jun, Lu, Selena A., Jove, Richard, Yim, John H.
Publicado 2018

Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer

por Wen, Wei, Han, Ernest S., Dellinger, Thanh H., Lu, Leander X., Wu, Jun, Jove, Richard, Yim, John H.
Publicado 2020

Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer

por Yuan, Yuan, Wen, Wei, Yost, Susan E., Xing, Quanhua, Yan, Jin, Han, Ernest S., Mortimer, Joanne, Yim, John H.
Publicado 2019

IRF-1 regulates alternative mRNA splicing of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in breast epithelial cells generating an immunoreceptor tyrosine-ba...

por Dery, Kenneth J, Kujawski, Maciej, Grunert, David, Wu, Xiwei, Ngyuen, Tung, Cheung, Celeste, Yim, John H, Shively, John E
Publicado 2014

Inhibition of Autophagy Amplifies Baicalein-Induced Apoptosis in Human Colorectal Cancer

por Phan, Thuy, Nguyen, Vu H., A’lincourt Salazar, Marcela, Wong, Paul, Diamond, Don J., Yim, John H., Melstrom, Laleh G.
Publicado 2020

Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer

por Wen, Wei, Han, Ernest S., Dellinger, Thanh H., Wu, Jun, Guo, Yuming, Buettner, Ralf, Horne, David A., Jove, Richard, Yim, John H.
Publicado 2019

Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer

por Wen, Wei, Wu, Jun, Liu, Lucy, Tian, Yan, Buettner, Ralf, Hsieh, Meng-Yin, Horne, David, Dellinger, Thanh H, Han, Ernest S, Jove, Richard, Yim, John H
Publicado 2015

Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience

por Yuan, Yuan, Yost, Susan E., Yim, John, Yuan, Yate-Ching, Solomon, Nicola M., Mambetsariev, Isa, Pal, Sumanta, Frankel, Paul, Salgia, Ravi, Neuhausen, Susan L., Mortimer, Joanne
Publicado 2017

Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes

por Wang, Lei, Simons, Diana L., Lu, Xuyang, Tu, Travis Y., Avalos, Christian, Chang, Andrew Y., Dirbas, Frederick M., Yim, John H., Waisman, James, Lee, Peter P.
Publicado 2020

Differential gene expression and AKT targeting in triple negative breast cancer

por Lin, Feng-Mao, Yost, Susan E., Wen, Wei, Frankel, Paul H., Schmolze, Daniel, Chu, Pei-Guo, Yuan, Yate-Ching, Liu, Zheng, Yim, John, Chen, Zhen, Yuan, Yuan
Publicado 2019

Human breast tumor-infiltrating CD8(+) T cells retain polyfunctionality despite PD-1 expression

por Egelston, Colt A., Avalos, Christian, Tu, Travis Y., Simons, Diana L., Jimenez, Grecia, Jung, Jae Y., Melstrom, Laleh, Margolin, Kim, Yim, John H., Kruper, Laura, Mortimer, Joanne, Lee, Peter P.
Publicado 2018

Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer

por Wen, Wei, Marcinkowski, Emily, Luyimbazi, David, Luu, Thehang, Xing, Quanhua, Yan, Jin, Wang, Yujun, Wu, Jun, Guo, Yuming, Tully, Dylan, Han, Ernest S., Yost, Susan E., Yuan, Yuan, Yim, John H.
Publicado 2019

Sentinel lymph node B cells can predict disease-free survival in breast cancer patients

por Blenman, Kim R. M., He, Ting-Fang, Frankel, Paul H., Ruel, Nora H., Schwartz, Erich J., Krag, David N., Tan, Lee K., Yim, John H., Mortimer, Joanne E., Yuan, Yuan, Lee, Peter P.
Publicado 2018

Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12

por Chung, Brile, Esmaeili, Ali A., Gopalakrishna-Pillai, Sailesh, Murad, John P., Andersen, Emily S., Kumar Reddy, Naveen, Srinivasan, Gayathri, Armstrong, Brian, Chu, Caleb, Kim, Young, Tong, Tommy, Waisman, James, Yim, John H., Badie, Behnam, Lee, Peter P.
Publicado 2017

Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer

por Lee, Jin Sun, Yost, Susan E., Blanchard, Suzette, Schmolze, Daniel, Yin, Hongwei Holly, Pillai, Raju, Robinson, Kim, Tang, Aileen, Martinez, Norma, Portnow, Jana, Wen, Wei, Yim, John H., Brauer, Heather Ann, Ren, Yuqi, Luu, Thehang, Mortimer, Joanne, Yuan, Yuan
Publicado 2019

Tumor-infiltrating exhausted CD8(+) T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer

por Egelston, Colt A., Guo, Weihua, Tan, Jiayi, Avalos, Christian, Simons, Diana L., Lim, Min Hui, Huang, Yinghui J., Nelson, Michael S., Chowdhury, Arnab, Schmolze, Daniel B., Yim, John H., Kruper, Laura, Melstrom, Laleh, Margolin, Kim, Mortimer, Joanne E., Yuan, Yuan, Waisman, James R., Lee, Peter P.
Publicado 2022